8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2024 / Narrative review
This review evaluates the advantages and disadvantages of modern pharmacologic and surgical weight management strategies for obesity. It examines data on anticipated weight loss, glycemic control, cardiometabolic improvements, and possible adverse outcomes associated with incretin-based drugs and bariatric metabolic surgery. The authors note that while lifestyle changes provide health benefits, weight loss from lifestyle alone is modest and hard to sustain.
Singh A, Nissen SE Diabetes Technol Ther, 2024. PMID 38669473
2024 / Narrative review
This review examines the epidemiology and management of gestational diabetes, which affects around 14% of pregnancies globally and incurs US$1.6 billion in direct costs in the USA. Between 30% and 70% of cases are diagnosed before 20 weeks of gestation, with early gestational diabetes associated with worse outcomes than diagnosis at 24 to 28 weeks. Randomized controlled trials demonstrate the benefits of treating gestational diabetes at 24 to 28 weeks, and the TOBOGM trial showed benefits from diagnosing and treating early gestational diabetes in women with risk factors.
Sweeting A, Hannah W, Backman H, et al. Lancet, 2024. PMID 38909620
2024 / Systematic review
This systematic review evaluated the physiological impacts of repeated weight cycling. It found that multiple cycles of weight loss and regain increased central fat deposition, decreased lean mass during weight loss, and increased fat mass during regain. Weight cycling also enhanced adipose tissue inflammation, contributed to pancreatic beta-cell fatigue and failure through hyperinsulinemia and glucose fluctuations, and placed an additional burden on the cardiovascular system. Physical activity combined with calorie restriction was noted to help reduce metabolic disease and chronic inflammation.
Wang H, He W, Yang G, et al. Metabolites, 2024. PMID 38921478
2023 / Narrative review
This review summarizes evidence indicating that high iron is a risk factor for type 2 diabetes mellitus (T2DM). High iron affects decreased insulin secretion, insulin resistance, and increased hepatic gluconeogenesis across both normal tissue iron ranges and pathologic overload. Iron levels influence metabolic rates, gluconeogenesis, fuel choice, insulin action, and adipocyte phenotype, with the adipocyte, beta cell, and liver playing central roles.
Harrison AV, Lorenzo FR, McClain DA Annu Rev Physiol, 2023. PMID 36137277
2023 / Editorial / narrative review
This editorial addresses the ethical, nutritional, and public health problems associated with the typical Western diet high in processed and animal-based foods. The authors state that animal-based foods drive mechanisms underlying chronic cardiometabolic disease, which whole-food plant-based nutrition can reverse. They also argue that factory farming contributes to climate change, antibiotic resistance, and infectious diseases, while nutritional resource distribution remains unjust. Consequently, the authors state that the medical profession has a duty to advocate for plant-based nutrition and nutrition equity.
Hull SC, Charles J, Caplan AL Am J Cardiol, 2023. PMID 36446227
2023 / Narrative review
This review examines semaglutide, approved for type 2 diabetes and obesity management. Manufacturer-sponsored randomized controlled trials showed a loss of almost 12% of body weight over 68 weeks, though individuals regain most of their pretreatment weight once medication is stopped. Gastrointestinal adverse events occur commonly, and pancreatitis, diabetic retinopathy, and severe allergic reactions have also been reported.
Lexchin J, Mintzes B Drug Ther Bull, 2023. PMID 37879878
2023 / Review
Obesity is a major public health concern associated with conditions like hypertension, type 2 diabetes, stroke, and cancer, affecting over a third of adults in the United States. While standard pharmacological agents such as lipase inhibitors and GLP-1 receptor agonists reduce weight gain by inhibiting fat absorption or stimulating satiety hormones, they are not effective for genetic disorders like Bardet-Biedl syndrome or POMC deficiency. Emerging therapies, including leptin analogs and MC4R agonists, target these genetic or hormonal causes to help regulate energy balance and appetite. The review discusses clinical trials, efficacy, FDA-approved indications, contraindications, and serious side effects of these medication classes.
Brandfon S, Eylon A, Khanna D, et al. Cureus, 2023. PMID 37937009
2023 / Narrative review
This narrative review examined position papers published by scientific, professional, and paediatric associations regarding vegan diets during infancy, childhood, and adolescence. Some associations support well-designed vegan diets with vitamin B12 supplementation and medical oversight, while others caution against them, citing potential harm, lack of substantiation, or reliance on lower-quality or outdated studies. The authors highlight the need for an up-to-date literature review and comparable assessments of both omnivorous and vegan diets.
Jakše B, Fras Z, Fidler Mis N Nutrients, 2023. PMID 38004109
2023 / Literature review
This literature review examined the effects of a vegan diet on adult health, beneficial components, and difficulties in implementation. Evidence supports that a vegan diet can reduce the risk of chronic conditions, including type 2 diabetes, hypertension, and specific cancers. The authors note that a well-planned vegan diet must ensure adequate calories, nutrients, and essential supplements such as vitamin B12, vitamin D, and EPA/DHA.
Łuszczki E, Boakye F, Zielińska M, et al. Front Nutr, 2023. PMID 38024367
2022 / Comprehensive review of human studies
This comprehensive review synthesized available human studies evaluating the health benefits and risks of consuming shellfish, including mollusks and crustaceans. Findings showed that shellfish intake may increase the risk of hyperuricemia and gout, but may not increase the risk of type 2 diabetes, cardiovascular diseases, or thyroid cancer. Adequate evidence was lacking regarding associations with colorectal, pancreatic, and oral cancers, endometriosis, hip fracture, cognitive function, wheeze, eczema, and food allergy. Additionally, raw shellfish consumption may cause gastroenteritis and other infections from bacteria or viruses.
Shows an association, not proof of cause and effect.
Xu L, Cai J, Gao T, et al. Crit Rev Food Sci Nutr, 2022. PMID 33527847
2022 / Narrative review
This narrative review provides an overview of the diagnosis and conservative treatment of patients with frozen shoulder (FS). Recommended interventions include mobilization techniques, exercises guided by tissue irritability, patient education, and pharmacotherapy, alongside newer practices like proprioceptive neuromuscular facilitation and mirror therapy. Interventions such as pain neuroscience education, high-intensity interval training, and lifestyle changes are noted as still hypothetical.
Mertens MG, Meeus M, Verborgt O, et al. Rheumatol Int, 2022. PMID 34487209
2022 / Narrative review
This review examines the physiological functions of GLP-1 and its development into pharmaceuticals for obesity and type 2 diabetes (T2DM). GLP-1 receptor agonists are highlighted as effective anti-obesity agents and recommended second-line therapies for T2DM, particularly for patients with increased cardiovascular risk. The author discusses proglucagon processing across tissues and notes that the relationship between endogenous GLP-1 actions and the clinical effects of agonists is far from congruent and generally poorly understood.
Holst JJ J Intern Med, 2022. PMID 34982496
2022 / Narrative review
This review summarizes clinical and preclinical evidence regarding the molecular and pharmacological activities of piperine. According to the review, piperine demonstrates antioxidant, anticancer, anti-inflammatory, and antihypertensive properties, and provides therapeutic benefits in conditions including diabetes, obesity, cardiovascular diseases, kidney diseases, and hypertension. These effects are mediated through the modulation of various signaling molecules, enzymes, pathways, and the gut microbiota.
Tripathi AK, Ray AK, Mishra SK Beni Suef Univ J Basic Appl Sci, 2022. PMID 35127957
2022 / Narrative review
This review examines the importance of NAD+ in human aging and survival, its biosynthesis, clinical trial findings, and the role of nicotinamide mononucleotide (NMN). Systemic decline in NAD+ is linked to the hallmarks of aging and various age-related disorders. Studies in mice and humans indicate that NMN supplementation offers therapeutic potential for chronic conditions such as diabetes, cardiovascular issues, and cognitive impairment. The authors note that further human interventions are required to investigate the long-term effects of varying NMN doses.
Soma M, Lalam SK Mol Biol Rep, 2022. PMID 35441939
2022 / Expert consensus statement using modified Delphi process
A multidisciplinary expert panel utilized a modified Delphi process informed by a systematic literature search to establish consensus on dietary interventions for type 2 diabetes (T2D) remission. Out of 131 candidate statements evaluated across 4 iterations, 69 reached consensus, 5 reached near-consensus, and 60 reached no consensus. The panel agreed that T2D remission is defined as HbA1c <6.5% for at least 3 months without glucose-lowering therapy or surgery, and that dietary intervention is most effective for remission when emphasizing whole, plant-based foods with minimal meat and animal products.
Rosenfeld RM, Kelly JH, Agarwal M, et al. Am J Lifestyle Med, 2022. PMID 35706589
2022 / Literature review
A review of multiple databases identified 104 relevant studies assessing the health effects of voluntary cold-water immersion (CWI) in humans. Studies indicated that CWI seems to reduce and/or transform body adipose tissue, reduce insulin resistance, and improve insulin sensitivity, which may offer protective effects against cardiovascular, obesity, and metabolic diseases. However, clear conclusions were limited by small sample sizes, often single-gender groups, and variations in water temperature and salt composition.
Esperland D, de Weerd L, Mercer JB Int J Circumpolar Health, 2022. PMID 36137565
2022 / Evidence-based dietary guideline
An Expert Panel developed a food-based intake recommendation for flavan-3-ols based on a review of 157 randomized controlled trials and 15 cohort studies using the Academy of Nutrition and Dietetics Evidence to Decision Framework. Moderate evidence supported cardiometabolic protection from dietary flavan-3-ol intake in the range of 400-600 mg/d. Increasing dietary intake was found to improve blood pressure, cholesterol levels, and blood sugar, with the strongest evidence for systolic blood pressure, total cholesterol, HDL cholesterol, and insulin/glucose dynamics. This recommendation is food-based and not intended for supplements.
Crowe-White KM, Evans LW, Kuhnle GGC, et al. Adv Nutr, 2022. PMID 36190328
2021 / Narrative review
This overview reviews the impact of polyphenols and polyphenolic foods on longevity and age-related conditions. Studies suggest dietary polyphenols can improve insulin resistance, diabetes risk factors, inflammation, and oxidative stress, and polyphenol intake is associated with reduced aging in humans. In vitro and in vivo evidence shows polyphenols ameliorate age-related phenotypes such as impaired proteostasis and cellular senescence, and the anti-aging action of polyphenol-rich diets like those in Blue zones is discussed.
Shows an association, not proof of cause and effect.
Meccariello R, D'Angelo S Antioxidants (Basel), 2021. PMID 33805092
2021 / Narrative review / hypothesis
This review notes that SARS-CoV-2 total infection and death rates have been lower in sub-Saharan Africa compared with North Africa, Europe, North America, and other regions. Published research correlates a younger population and a native plant-based diet (including whole grains, legumes, vegetables, tubers, and lower meat consumption) with lower risk factors such as metabolic syndrome, obesity, diabetes, and dysbiosis. The authors note that these hypotheses need to be supported by more clinical and biostatistical data.
Shows an association, not proof of cause and effect.
Losso JN, Losso MN, Toc M, et al. Plant Foods Hum Nutr, 2021. PMID 34169470
2021 / Commentary on clinical evidence
This commentary highlights findings from Yoshino et al. (2021) regarding NAD+ boosters. The authors note that clinical evidence demonstrates an NAD+ booster increases muscle insulin sensitivity in postmenopausal prediabetic women. This validates the therapeutic potential of NAD+ boosters in humans for addressing metabolic disorders associated with aging and obesity.
Montllor-Albalate C, Song Z, Chen D Cell Metab, 2021. PMID 34233170
2021 / Narrative review
This review examines the relationship between diabetes and sensorineural hearing loss. Individuals with diabetes have twice the incidence of hearing loss compared to those without diabetes, and those with prediabetes have a 30% higher rate of hearing loss. While type 1 and type 2 diabetes are associated with hearing loss, establishing a causal link has been difficult, and whether this association is independent of glycemic control remains to be determined.
Shows an association, not proof of cause and effect.
Samocha-Bonet D, Wu B, Ryugo DK Ageing Res Rev, 2021. PMID 34384902
2021 / Consensus report
An international expert group convened by the American Diabetes Association met to propose standardized nomenclature and objective measures for sustained glucose improvement in type 2 diabetes. The group proposed 'remission' as the most appropriate term and suggested HbA1c <6.5% (48 mmol/mol) measured at least 3 months after cessation of glucose-lowering pharmacotherapy as the usual diagnostic criterion. Recommendations were also provided for active observation of patients experiencing remission and for addressing unmet needs regarding predictors and outcomes.
Riddle MC, Cefalu WT, Evans PH, et al. Diabetes Care, 2021. PMID 34462270
2021 / Narrative review
This review summarizes scientific data on the preventive and therapeutic roles of plant-based diets (vegan and lacto-ovo-vegetarian) in cardiovascular disease, cancer, diabetes, obesity, and osteoporosis. The authors report that plant-based diets are safe and effective for all life cycle stages, including pregnancy, lactation, childhood, and old age, and are associated with a diverse gut microbiota. Nutritional concerns regarding intake of vitamin B12, calcium, vitamin D, iron, zinc, and omega-3 fats are discussed alongside guidance on fortified foods and supplementation.
Craig WJ, Mangels AR, Fresán U, et al. Nutrients, 2021. PMID 34836399
2021 / Review of prospective cohort studies
This review evaluated the impact of adjusting for diet quality or dietary patterns on reported associations between ultra-processed food (UPF) intake and health outcomes in prospective cohort studies. The authors found that the majority of associations between UPFs, obesity, and health-related outcomes remained significant and unchanged in magnitude after adjusting for diet quality or pattern. These findings suggest that the adverse consequences of UPFs are independent of dietary quality or pattern.
Shows an association, not proof of cause and effect.
Dicken SJ, Batterham RL Nutrients, 2021. PMID 35010898